NCT05237869

Brief Summary

Lateral epicondylitis (LE), often referred to as "tennis elbow" is a common and debilitating overuse injury affecting 1-3% of adults annually. LE is most often defined as a syndrome of pain near the area of the lateral epicondyle of the elbow commonly effecting the origin of the extensor carpi radialis brevis with associated weakness; it most commonly effects the dominant arm. The best treatment for LE is unknown and research to support current treatment methods are insufficient. A common limitation in functional recovery experienced by this population is pain at the lateral aspect of the elbow. As such, innovative therapeutic interventions directed at quickly reducing pain may address this unmet need and allow for improved outcomes, as well as earlier return to function.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 27, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 14, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

May 20, 2022

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

April 25, 2025

Status Verified

April 1, 2025

Enrollment Period

3.9 years

First QC Date

December 27, 2021

Last Update Submit

April 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Define the effect of BFR training on pain with activity in patients with LE.

    Measured on a 0-10 scale by VAS (Visual Analog Scale) patient reported outcome form. The VAS is scored 0-10, and a higher score indicates worse pain/worse outcomes.

    3 weeks to 6 months

Study Arms (2)

Physical Therapy

SHAM COMPARATOR

For patients enrolled in the control group, the participants will undergo calibration of the Delfi Personalized Tourniquet System to measure limb occlusion pressure and will wear the cuff during completion of the exercises with minimal inflation (approximately 5%), to hold the cuff in place during treatment. This will act as a sham.

Other: Standard Physical Therapy

Blood Flow Restricted Physical Therapy

ACTIVE COMPARATOR

Physical therapy assisted by blood flow restriction per standard physical therapy protocol.

Device: Blood Flow Restriction Device

Interventions

Occlusion training involves the application of a cuff to the upper arm that is designed to restrict only the low-pressure blood flow in veins. It does not prevent blood flowing from the heart to the arm.

Blood Flow Restricted Physical Therapy

Standard physical therapy protocol for lateral epicondylitis rehab without blood flow restriction.

Physical Therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 18-65 years of age
  • Diagnosis of lateral epicondylitis confirmed by the treating orthopaedic surgeon and ultrasound
  • Must be able to read and write in English
  • Able to provide own written consent

You may not qualify if:

  • Patients over 65 years of age
  • Contralateral upper extremity involvement resulting in less than normal range of motion, muscle strength or daily pain greater than 1/10
  • History of prior injection for treatment of lateral epicondylitis
  • Pregnancy
  • Recent history of deep venous thrombosis (within the past 12 months)
  • Active treatment with anticoagulants
  • History of upper quadrant lymph node dissection
  • History of endothelial dysfunction
  • Patient history of easy bruising
  • Active infection in the injured arm
  • Cancer
  • Uncontrolled peripheral vascular disease
  • Uncontrolled diabetes mellitus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vicki Jones

Columbia, Missouri, 65212, United States

RECRUITING

MeSH Terms

Conditions

Tennis Elbow

Condition Hierarchy (Ancestors)

Elbow TendinopathyTendinopathyMuscular DiseasesMusculoskeletal DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon Injuries

Study Officials

  • Julia Nuelle, MD

    University of Missouri Department of Orthopaedic Surgery

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vicki Jones, MEd, CCRP

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
For patients enrolled in the control group, the participants will undergo calibration of the Delfi Personalized Tourniquet System to measure limb occlusion pressure and will wear the cuff during completion of the exercises with minimal inflation (approximately 5%), to hold the cuff in place during treatment. This will act as a sham.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor of Orthopaedic Surgery, Hand Surgeon

Study Record Dates

First Submitted

December 27, 2021

First Posted

February 14, 2022

Study Start

May 20, 2022

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

April 25, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations